Open flow microperfusion can be used to assess the amount of a topically applied drug directly in the skin. Large intra-and interindividual differences in skin properties can lead to biased results. In this study we propose a method based on skin impedance measurements to assess the properties of the skin barrier and thus compensate for varying permeability characteristics.
Introduction
Open flow microperfusion (OFM) is a method for continuous sampling of interstitial fluid (ISF) from various tissues of animals and humans. Subsequent analysis of the OFM samples delivers time resolved profiles of many analytes covering a wide range of molecule sizes and chemical properties (e.g. hydrophilicity, lipophilicity). OFM is based on minimally invasive probes with an exchange area featuring macroscopic openings. During the sampling process the probes are perfused with a carrier fluid which mixes with the interstitial fluid of the target tissue. The exchange of carrier fluid and tissue fluid takes place at a certain equilibrium level that allows to measure specific substances present in the tissue by downstream analysis in the bioanalytical lab. OFM is used to investigate drug penetration and drug efficacy in skin in vivo: a probe is placed in the skin, and the cream containing the active ingredient is applied to the skin site directly above the probe. However, there are large individual differences in skin conditions depending on the location of the test site (e.g. forearm, abdomen thigh) and is also dependant on the subject itself (e.g. skin type, environmental conditions). To correct for these differences that will affect the variability of OFM derived drug profiles a large number of skin donors is necessary to reliably test topical drug penetration. In this study we aimed to investigate whether skin impedance measurements can be used to predict at least some of the skin's permeability characteristics.
Methods
Our study is based on the hypothesis that variations in penetrating drug amounts during dermal OFM sampling can be correlated with variations of the passive electrical parameters of the skin. Fresh human skin from plastic surgery was mounted on an ex-vivo test unit (EVA-CELL, Joanneum Research, Graz) to maintain skin vitality and temperature. Skin impedance of each donor skin flap was assessed by using paediatric ECG electrodes in a 3-electrode setting. The electrodes were attached in an equilateral triangle with a side length of 5 cm. The distance between the electrodes was chosen to be 2.5 cm with an electrode diameter of also 2.5 cm. This symmetrical setup allowed moving the three electrodes types (reference, counter and working electrode) simply by varying reconnection of the electrodes to the potentiostat. Impedance spectroscopy and single frequency measurements were used to assess stratum corneum impedance. Clobetasol-17-proprionate (CP17) was applied topically on the skin flaps characterized with the impedance measurements and the penetration of the drug into the dermis was continuously profiled for 24 h by using dermal OFM sampling. 
Results
To study at what frequencies the skin layers responsible for the barrier function for skin penetration are assessed impedance spectra were recorded from 1000 to 1 Hz with 5 data points per frequency decade. We found that low frequencies below 100 Hz showed a significant correlation to skin penetration properties. The sensitivity of the measurement increases with decreasing frequency which is in good agreement with data from the literature [1]. At higher frequencies also deeper parts of the skin and the subcutaneous tissue contribute to the impedance measured, therefore lower frequencies, which assess only the top layers of the skin, or the stratum corneum only in an optimal case, are more sensitive to penetration properties of the skin. Fig. 2 : at low frequencies a significant higher sensitivity to skin penetration properties is observed.
To investigate the relationship between skin impedance and penetrated quantities of CP17, the impedance was plotted against the area under the curve (AUC) of the CP17 concentration over 24 h, a standard measure used in pharmacokinetics. Regression analysis revealed a clear relationship between impedance and the penetrated CP17 amount. The correlation of skin impedance and drug penetration properties of the skin can be used to normalize dermal OFM AUC values thus eliminating or minimizing the influence of intra-and interindividual differences in skin properties. Fig. 3 : skin properties variations leading to impedance measurements (n=5).
Discussion
Our results support the hypothesis that the stratum corneum is the main source of variability when testing topical drug penetration into human skin ex-vivo. We conclude that skin impedance measurements can be helpful to characterize skin barrier properties and thus support future ex-vivo and in-vivo skin penetration studies using dOFM sampling. Skin impedance measurements can be used to screen skin properties before OFM studies were performed. Restricting the accepted penetration properties of study subjects to the range representing the population average could significantly reduce the number of subjects needed and thus reduce study costs.
